Clinical Trial Update: Evaluation of the Use of Thrombopoietin Receptor Agonists in Adults With Primary ITP in Europe

View source ↗

Summary

A European clinical trial evaluating thrombopoietin receptor agonists for adults with primary immune thrombocytopenia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Immune Thrombocytopenia

Snippet

Sponsor: European Research Consortium on ITP | Conditions: Primary Immune Thrombocytopenia (ITP) | Status: COMPLETED